XML 62 R50.htm IDEA: XBRL DOCUMENT v3.25.3
NOTE 11 - BUSINESS SEGMENT INFORMATION: Schedule of Segment Reporting Information, by Segment (Tables)
9 Months Ended
Sep. 30, 2025
March 31, 2024  
Schedule of Segment Reporting Information, by Segment

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

BergaMet

UBN

Revenue

2,817,910

2,817,910

-

-

Cost of Revenue

1,352,848

1,352,848

-

-

Long-lived Assets

715,141

212,414

502,727

-

Gain (Loss) Before Income Tax

(727,133)

8,140

(300)

(734,973)

Identifiable Assets

966,522

966,522

-

-

Depreciation and Amortization

1,329

1,329

-

-

March 31, 2023  
Schedule of Segment Reporting Information, by Segment

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

BergaMet

UBN

Revenue

2,342,091

2,342,091

-

-

Cost of Revenue

845,185

845,185

-

-

Long-lived Assets

732,030

193,260

538,771

-

Gain (Loss) Before Income Tax

(393,742)

364,817

(770)

(757,789)

Identifiable Assets

1,443,505

1,443,505

-

-

Depreciation and Amortization

343

343

-

-